Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCLC Stage C HCC”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableNot Yet RecruitingNCT07807475
What this trial is testing

DNP-MRSI of HCC Metabolism to Predict Therapeutic Response

Who this might be right for
Barcelona Clinic Liver Cancer (BCLC) Stage A, B or C HCC
Abramson Cancer Center at Penn Medicine 232
Testing effectiveness (Phase 2)Looking for participantsNCT07274774
What this trial is testing

SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 184
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Testing effectiveness (Phase 2)WithdrawnNCT05327738
What this trial is testing

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaLocally Advanced Hepatocellular Carcinoma+2 more
OHSU Knight Cancer Institute
Not applicableNot Yet RecruitingNCT06971237
What this trial is testing

SIRT and Peri-immunotherapy : a New Concept

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)UnknownNCT04992143
What this trial is testing

TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC

Who this might be right for
BCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 20
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Testing effectiveness (Phase 2)Ended earlyNCT04442581
What this trial is testing

Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
University of Washington 2
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507632
What this trial is testing

Donafenib Plus Sintilimab in Combination With TACE in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Nanfang Hospital, Southern Medical University 48
Large-scale testing (Phase 3)UnknownNCT04909866
What this trial is testing

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Who this might be right for
Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Large-scale testing (Phase 3)Study completedNCT03164382
What this trial is testing

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatic Carcinoma
Sun Yat-sen University 262
Testing effectiveness (Phase 2)UnknownNCT04483284
What this trial is testing

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 28
Not applicableStudy completedNCT06261138
What this trial is testing

Survival Analysis: TACE vs. Combination Therapy in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 279
Not applicableStudy completedNCT06631326
What this trial is testing

HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)

Who this might be right for
HCC - Hepatocellular CarcinomaHepatic Arterial Infusion ChemotherapyBCLC Stage C Hepatocellular Carcinoma+2 more
First Hospital of China Medical University 244
Testing effectiveness (Phase 2)UnknownNCT04191889
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification

Who this might be right for
C-staged Hepatocellular Carcinoma in BCLC Classification
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Looking for participantsNCT07062055
What this trial is testing

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more
Shandong Cancer Hospital and Institute 54
Testing effectiveness (Phase 2)UnknownNCT04814030
What this trial is testing

Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 80
Not applicableActive Not RecruitingNCT04736121
What this trial is testing

Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients

Who this might be right for
Unresectable Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+1 more
Sirtex Medical 100
Next Page